C1q Binding Assays | Abzena

C1q Binding

C1q is the first component of the classical complement pathway. IgG1, IgG2, IgG3 and IgMs are capable of fixing complement and initiating the classical pathway, however, activation of the complement cascade is strictly controlled and only occurs when the antibody is bound to its antigen.

Our C1q ELISA measures the binding of purified human C1q to antibodies or ADCs directly coated on a plate.

Working with Abzena

Abzena’s undertakes bioassays on behalf of clients as standalone projects or as part of larger development projects. We focus on developing the correct bioassay to help you understand your molecule and will help guide you in the correct.

To get more information, a quote or to schedule a teleconference please contact us.


C1q Binding ELISA: Rituximab can fix C1q in a dose-dependent manner
Interested in our services? Get In Touch